Chimeric receptors to FLT3 and methods of use thereof

MYPI2025001539A0Undetermined Publication Date: 2017-10-01AMGEN INC +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
MYPI2025001539
Authority / Receiving Office
MY · MY
Patent Type
Applications
Current Assignee / Owner
Priority Date
2016-04-01
Filing Date
2017-03-31
Publication Date
2017-10-01
Patent Text Reader

Abstract

Antigen binding molecules, chimeric receptors, and engineered immune cells to FLT3 are disclosed in accordance with the invention. The invention further relates to vectors, compositions, and methods of treatment and / or detection using the FLT3 antigen binding molecules and engineered immune cells. No suitable figure
Need to check novelty before this filing date? Find Prior Art